[HTML][HTML] Advances in fungal peptide vaccines
L BR Da Silva, C P. Taborda, J D. Nosanchuk - Journal of fungi, 2020 - mdpi.com
Vaccination is one of the greatest public health achievements in the past century, protecting
and improving the quality of life of the population worldwide. However, a safe and effective …
and improving the quality of life of the population worldwide. However, a safe and effective …
[HTML][HTML] Paracoccidioidomycosis protective immunity
E Burger - Journal of Fungi, 2021 - mdpi.com
Protective immunity against Paracoccidioides consists of a stepwise activation of numerous
effector mechanisms that comprise many cellular and soluble components. At the initial …
effector mechanisms that comprise many cellular and soluble components. At the initial …
[PDF][PDF] de Paula e Silva
L Scorzoni - 2004 - pdfs.semanticscholar.org
Background: Paracoccidioidomycosis (PCM) is a chronic disease that causes sequelae and
requires prolonged treatment; therefore, new therapeutic approaches are necessary. In view …
requires prolonged treatment; therefore, new therapeutic approaches are necessary. In view …
Vaccine development for pathogenic fungi: current status and future directions
JL Chechi, FAC da Costa, JM Figueiredo… - Expert Review of …, 2023 - Taylor & Francis
Introduction Fungal infections are caused by a broad range of pathogenic fungi that are
found worldwide with different geographic distributions, incidences, and mortality rates …
found worldwide with different geographic distributions, incidences, and mortality rates …
[HTML][HTML] Identification of Potentially Therapeutic Immunogenic Peptides From Paracoccidioides lutzii Species
Paracoccidioidomycosis (PCM) is an endemic mycosis in Latin America caused by the
thermodimorphic fungi of the genus Paracoccidioides spp. Paracoccidioides lutzii (PL) is …
thermodimorphic fungi of the genus Paracoccidioides spp. Paracoccidioides lutzii (PL) is …
[HTML][HTML] In Vitro and In Vivo Effect of Peptides Derived from 14-3-3 Paracoccidioides spp. Protein
L Scorzoni, AC Alves de Paula e Silva, HC de Oliveira… - Journal of Fungi, 2021 - mdpi.com
Background: Paracoccidioidomycosis (PCM) is a chronic disease that causes sequelae and
requires prolonged treatment; therefore, new therapeutic approaches are necessary. In view …
requires prolonged treatment; therefore, new therapeutic approaches are necessary. In view …
Fungal Extracellular Vesicles as a Potential Strategy for Vaccine Development
Extracellular vesicles (EVs) are released by virtually all live cells. In fungal organisms, the
EVs traverse the cell wall and reach the extracellular environment, where they can interact …
EVs traverse the cell wall and reach the extracellular environment, where they can interact …
The story of Paracoccidiodes gp43
R Puccia, CP Taborda - Brazilian Journal of Microbiology, 2023 - Springer
This review is about Dr. Luiz Rodolpho Raja Gabaglia Travassos' scientific contributions to
paracoccidioidomycosis as told by myself, Rosana Puccia, but co-written with Dr. Carlos P …
paracoccidioidomycosis as told by myself, Rosana Puccia, but co-written with Dr. Carlos P …
[HTML][HTML] Transcriptional Remodeling Patterns in Murine Dendritic Cells Infected with Paracoccidioides brasiliensis: More Is Not Necessarily Better
CM de-Souza-Silva, FA Hurtado, AH Tavares… - Journal of Fungi, 2020 - mdpi.com
Most people infected with the fungus Paracoccidioides spp. do not get sick, but
approximately 5% develop paracoccidioidomycosis. Understanding how host immunity …
approximately 5% develop paracoccidioidomycosis. Understanding how host immunity …
[HTML][HTML] Monocyte-Derived Dendritic Cells Can Revert In Vitro Antigen-Specific Cellular Anergy in Active Human Paracoccidioidomycosis
We investigated the in vitro effects of two Paracoccidioides brasiliensis antigens on
monocyte-derived dendritic cells (moDCs) from patients with paracoccidioidomycosis …
monocyte-derived dendritic cells (moDCs) from patients with paracoccidioidomycosis …